Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Interest Expense

: $-73 Mil (TTM As of Jun. 2023)

View and export this data going back to 2009. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aspen Pharmacare Holdings's interest expense for the six months ended in Jun. 2023 was $ -48 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-73 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aspen Pharmacare Holdings's Operating Income for the six months ended in Jun. 2023 was $ 269 Mil. Aspen Pharmacare Holdings's Interest Expense for the six months ended in Jun. 2023 was $ -48 Mil. Aspen Pharmacare Holdings's Interest Coverage for the quarter that ended in Jun. 2023 was 5.56. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aspen Pharmacare Holdings Interest Expense Historical Data

The historical data trend for Aspen Pharmacare Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

-152.69

-96.42

-86.61

-48.37

-70.63

Aspen Pharmacare Holdings Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense																-42.26	-27.94	-20.30	-24.07	-48.44

Aspen Pharmacare Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-73 Mil.

Aspen Pharmacare Holdings (OTCPK:APNHY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aspen Pharmacare Holdings's Interest Expense for the six months ended in Jun. 2023 was $-48 Mil. Its Operating Income for the six months ended in Jun. 2023 was $269 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was $1,140 Mil.

Aspen Pharmacare Holdings's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2023 )	/	Interest Expense (Q: Jun. 2023 )
	=	-1	*	269.248	/	-48.44
	=	5.56

The higher the ratio, the stronger the company's financial strength is.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

APN:South Africa

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023